SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novoste (novt)
NOVT 111.14-6.6%Jan 2 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: vaipor who wrote (87)1/10/2001 9:06:44 PM
From: Oak Tree  Read Replies (1) of 100
 
Good luck with the drug coated stents, the experimental results are not striking. Radiation is the best treatment in many years, and in animals perfectly prevents restenosis. The problem is the very high expense. If radiation dies it will be for cost. However, if I (or anyone I love) ever need an angioplasty, I will insist on radiation. Novoste as a company must get medicare to make an acceptable reimbursement. The current is $2400 and the cost per procedure is $3300. So the hospital's loss is $900 per case not including the lost MD time, the lost Cath lab time, and so forth. Thus, medically, radiation wins, economically chemotherapy coated stents may be better than non-chemotherapy coated stents.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News